We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFIC icon
13701
CALL
Dimensional International Core Equity 2 ETF
DFIC
$15.3B
$2.43K ﹤0.01%
+100
New +$2.43K
HLF icon
13702
Herbalife
HLF
$1.29B
$2.42K ﹤0.01%
+183
New +$2.49K
LAUR icon
13703
PUT
Laureate Education
LAUR
$5.18B
$2.42K ﹤0.01%
200
-700
-78% -$8.39K
MOBVW
13704
DELISTED
Mobiv Acquisition Corp Warrant
MOBVW
$2.41K ﹤0.01%
50,268
+10,284
+26% +$407
SLGL icon
13705
CALL
Sol-Gel Technologies
SLGL
$277M
$2.4K ﹤0.01%
+80
New +$2.8K
VIRX
13706
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.4K ﹤0.01%
1,700
-200
-11% -$286
POWW icon
13707
Outdoor Holding Co
POWW
$260M
$2.39K ﹤0.01%
1,124
-356,848
-100% -$697K
TRVI icon
13708
CALL
Trevi Therapeutics
TRVI
$2.63B
$2.39K ﹤0.01%
1,000
-100
-9% -$252
ACACW
13709
DELISTED
Acri Capital Acquisition Corp Warrant
ACACW
$2.38K ﹤0.01%
+41,120
New +$2.23K
GFGDR
13710
DELISTED
The Growth for Good Acquisition Corporation Right
GFGDR
$2.38K ﹤0.01%
16,961
-10,373
-38% -$1.57K
TBIO
13711
CALL
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$2.37K ﹤0.01%
83
-1,317
-94% -$52.6K
LVWR icon
13712
PUT
LiveWire
LVWR
$246M
$2.36K ﹤0.01%
+200
New +$1.66K
UAMY icon
13713
PUT
United States Antimony
UAMY
$825M
$2.36K ﹤0.01%
7,500
+1,100
+17% +$378
VREX icon
13714
PUT
Varex Imaging
VREX
$779M
$2.36K ﹤0.01%
+100
New +$2.08K
TX icon
13715
Ternium
TX
$10.6B
$2.34K ﹤0.01%
59
-3,562
-98% -$144K
IMDX
13716
CALL
Insight Molecular Diagnostics
IMDX
$141M
$2.32K ﹤0.01%
+505
New +$2.54K
CTEV
13717
PUT
Claritev Corp
CTEV
$646M
$2.32K ﹤0.01%
28
+5
+22% +$267
DYAI icon
13718
PUT
Dyadic International
DYAI
$28.2M
$2.32K ﹤0.01%
1,200
-600
-33% -$1.18K
WE
13719
DELISTED
WeWork Inc.
WE
$2.31K ﹤0.01%
227
-1,561
-87% -$21.6K
ADAP
13720
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
$2.31K ﹤0.01%
2,500
QUOT
13721
PUT
DELISTED
Quotient Technology Inc
QUOT
$2.3K ﹤0.01%
600
+500
+500% +$1.55K
ARVL
13722
PUT
DELISTED
Arrival Ordinary Shares
ARVL
$2.3K ﹤0.01%
892
-1,634
-65% -$5.17K
HUMA icon
13723
CALL
Humacyte
HUMA
$163M
$2.29K ﹤0.01%
+800
New +$2.88K
LGHL
13724
CALL
Lion Group Holding
LGHL
$729K
0
EMKR
13725
PUT
DELISTED
Emcore Corp
EMKR
$2.26K ﹤0.01%
300

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.